0000950170-24-048467.txt : 20240425 0000950170-24-048467.hdr.sgml : 20240425 20240425170834 ACCESSION NUMBER: 0000950170-24-048467 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20240424 FILED AS OF DATE: 20240425 DATE AS OF CHANGE: 20240425 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Mates Sharon CENTRAL INDEX KEY: 0001585699 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36274 FILM NUMBER: 24877398 MAIL ADDRESS: STREET 1: C/O INTRA-CELLULAR THERAPIES, INC. STREET 2: 3960 BROADWAY CITY: NEW YORK STATE: NY ZIP: 10032 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Intra-Cellular Therapies, Inc. CENTRAL INDEX KEY: 0001567514 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 364742850 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 430 EAST 29TH STREET CITY: NEW YORK STATE: NY ZIP: 10016 BUSINESS PHONE: 212-923-3344 MAIL ADDRESS: STREET 1: 430 EAST 29TH STREET CITY: NEW YORK STATE: NY ZIP: 10016 FORMER COMPANY: FORMER CONFORMED NAME: Oneida Resources Corp. DATE OF NAME CHANGE: 20130122 4 1 ownership.xml 4 X0508 4 2024-04-24 0001567514 Intra-Cellular Therapies, Inc. ITCI 0001585699 Mates Sharon C/O INTRA-CELLULAR THERAPIES, INC. 430 EAST 29TH STREET NEW YORK NY 10016 true true false false Chairman and CEO false Common Stock 2024-04-24 4 M false 8638 16.86 A 1058947 D Common Stock 2024-04-24 4 M false 11382 17.57 A 1070329 D Stock Option (right to buy) 16.86 2024-04-24 4 M false 8638 0 D 2024-06-30 Common Stock 8638 0 D Stock Option (right to buy) 17.57 2024-04-24 4 M false 11382 0 D 2025-01-02 Common Stock 11382 216998 D This option was granted on June 30, 2014 with an exercise price of $16.86 per share and will expire on June 30, 2024. All shares underlying this option have vested. This option was granted on January 2, 2015 with an exercise price of $17.57 per share and will expire on January 2, 2025. All shares underlying this option have vested. /s/ Lawrence J. Hineline, Attorney-in-fact 2024-04-25